Anatara Lifesciences : Notification regarding unquoted securities - ANR

About this update from Anatara Lifesciences Ltd

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Announcement Summary For personal use only Entity name ANATARA LIFESCIENCES LTD Date of this announcement Monday December 13, 2021 The +securities the subject of this notification are: +Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends Total number of +securities to be issued/transferred Total number of ASX +security +securities to be code Security description issued/transferred Issue date New class - code Options expiring 14 November 2025 exercisable at 1,800,000 09/12/2021 to be confirmed $0.225 ea Refer to next page for full details of the announcement Notification of Issue, Conversion or Payment up of Unquoted 1 / 7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 1 - Entity and announcement details For personal use only 1.1 Name of entity ANATARA LIFESCIENCES LTD We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type Registration number ABN 41145239872 1.3 ASX issuer code ANR The announcement is New announcement Date of this announcement 13/12/2021 Notification of Issue, Conversion or Payment up of Unquoted 2 / 7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 2 - Issue details For personal use only 2.1 The +securities the subject of this notification are: +Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends 2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which: does not have an existing ASX security code ("new class") Notification of Issue, Conversion or Payment up of Unquoted 3 / 7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B For personal use only New +securities issued under an +employee incentive scheme ASX +security code +Security description New class - code to be confirmed Options expiring 14 November 2025 exercisable at $0.225 ea +Security type ISIN code Options Date the +securities the subject of this notification were issued 9/12/2021 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes Provide details of the KMP or +associates being issued +securities. Name of KMP Name of registered holder Number of +securities 900,000 David Brookes - Director David Brookes 450,000 Sue MacLeman - Director Dalroar Pty Ltd as t'ee for MacLeman Investment Trust 450,000 Jane Ryan - Director Jane Ryan Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1? Yes Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued. Approved by Shareholders at the Annual General Meeting held on 16 November 2021. https://anataralifesciences.com/investors/corporate-governance/ Options Details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.22500000 14/11/2025 Notification of Issue, Conversion or Payment up of Unquoted 4 / 7 Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option Other Description only Options exercisable at $0.225 ea and expire 14 November 2025 Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms https://anataralifesciences.com/investors/corporate-governance/ Any other information the entity wishes to provide about the +securities the subject of this notification David Brookes: 900,000 at $0.225 ea; vesting 450,000 16 November 2022 & 450,000 16 November 2023; expire 14 November 2025 Dalroar Pty Ltd as t'ee for MacLeman Investment Trust (Sue MacLeman): 450,000 at $0.225 ea; vesting 225,000 16 November 2022 & 225,000 16 November 2023; expire 14 November 2025 Jane Ryan: 450,000 at $0.225 ea; vesting 225,000 16 November 2022 & 225,000 16 November 2023; expire 14 November 2025 use Issue details For personal Number of +securities 1,800,000 Notification of Issue, Conversion or Payment up of Unquoted 5 / 7 This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Anatara Lifesciences Ltd